Yes, citalopram is the primary culprit—it can cause hyponatremia through SIADH, particularly in older adults.
Among the medications listed, citalopram (an SSRI) carries the most significant risk for hyponatremia and requires immediate attention. The other medications pose minimal to no risk for causing low sodium.
Citalopram: High Risk for Hyponatremia
Citalopram explicitly causes hyponatremia through syndrome of inappropriate antidiuretic hormone secretion (SIADH), as documented in FDA labeling 1. The mechanism involves:
- Enhanced antidiuretic hormone secretion leading to water retention and dilutional hyponatremia
- Cases with serum sodium <110 mmol/L have been reported 1
- Hyponatremia was reversible upon discontinuation 1
Risk Factors Present in This Case:
- Elderly patients are at substantially greater risk with SSRIs 1
- Concomitant diuretic use (none listed here, but important to note)
- Volume depletion increases risk 1
Clinical Presentation to Monitor:
Watch for headache, difficulty concentrating, memory impairment, confusion, weakness, and unsteadiness leading to falls. Severe cases manifest as hallucinations, syncope, seizures, coma, respiratory arrest, or death 1.
Evidence Strength:
Multiple case reports document severe symptomatic hyponatremia with citalopram specifically 2, 3. A large pharmacovigilance analysis identified citalopram among the top 5 drugs by case count (n=738) for hyponatremia 4. Recent cohort data show SSRIs including citalopram carry 6.9-10.2% incidence of hyponatremia 5, 6.
The 2019 AGS Beers Criteria specifically added tramadol to the list of drugs associated with hyponatremia/SIADH 7, reinforcing that medication-induced hyponatremia remains a priority concern in older adults.
Other Medications: Minimal to No Risk
Metformin: No Direct Risk
Metformin does not cause hyponatremia. It may actually be protective in some contexts, though this is not clinically relevant here.
Fenofibrate: No Established Risk
Fenofibrate is not associated with hyponatremia in clinical practice or literature.
Prempro (Conjugated Estrogen/Medroxyprogesterone): No Direct Risk
Hormone replacement therapy does not cause hyponatremia through SIADH or other mechanisms.
Supplements (Magnesium, Zinc, Vitamin C, Vitamin D): No Risk
These supplements do not cause hyponatremia. Magnesium depletion can occur with diuretics 8, but magnesium supplementation itself does not lower sodium.
Docusate Sodium: No Risk
Despite containing sodium in its name, docusate sodium is a stool softener that does not affect serum sodium levels. Excessive laxative use could theoretically cause volume depletion, but docusate specifically does not cause hyponatremia.
Clinical Action Plan
Immediate Assessment:
- Check serum sodium level if not recently done
- Assess volume status (orthostatic vitals, mucous membranes, skin turgor)
- Review timing: Hyponatremia typically develops within the first few months of SSRI therapy 9
If Hyponatremia Confirmed (Serum Sodium <130 mEq/L):
For asymptomatic mild hyponatremia (>120 mEq/L) 10:
- Fluid restriction to 1-1.5 L daily
- Consider dose reduction or discontinuation of citalopram
- Monitor sodium every 5-7 days until stable
For severe or symptomatic hyponatremia (<120 mEq/L or symptomatic) 11:
- Discontinue citalopram immediately 1
- Hospitalize for monitoring
- Correct sodium slowly: no more than 10 mmol/L per day 11 to avoid osmotic demyelination syndrome
- Consider hypertonic saline only if severely symptomatic (seizures, altered mental status)
Critical Pitfall to Avoid:
Do not restart citalopram or switch to another SSRI/SNRI without careful consideration. A documented case showed recurrent hyponatremia when switching from citalopram to mirtazapine after 5 months 9, though mirtazapine generally carries lower risk 5, 6. If antidepressant therapy must continue, bupropion shows the lowest hyponatremia risk among common antidepressants (HR 0.83 compared to sertraline) 6.